Bone Therapeutics SA: Transparency notification received from CPH Banque
PRESS RELEASE – REGULATED INFORMATION Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major...
Month: December 2020
Algernon Pharmaceuticals Announces Acceleration of Expiry Date of Warrants
VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Chiesi Global Rare Diseases Announces First Patient Treated in Expanded Access Program for Pegunigalsidase Alfa for Proposed Treatment of Fabry Disease
- Program grants access to investigational therapy for Fabry disease patients in the United States who cannot be adequately treated...
Ocugen Establishes Vaccine Scientific Advisory Board
Leading experts to evaluate the clinical and regulatory path to approval in the US market of COVAXIN™, a whole-virion inactivated...
Novelion Announces Court Approval for Interim Distribution to Registered Shareholders
VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (“Novelion” or the “Company”) by Alvarez & Marsal...
KemPharm Announces 1-for-16 Reverse Stock Split
CELEBRATION, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery...
Afya Limited Announces Share Buyback Program
NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today...
10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in...
Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program
BATON ROUGE, La., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and...
NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2020
Data presented throughout 2020 have validated the potential of the PATrOL™ platform to develop highly targeted therapies that increase, decrease...
Ziopharm to Participate in Upcoming January Conferences
BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq: ZIOP), today announced that Laurence...
Altimmune Provides an Update on its Investigational New Drug Application for a Phase 1 AdCOVID™ Clinical Trial
GAITHERSBURG, Md., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the...
Acasti Pharma Unaware of Any Material Change
LAVAL, Québec, Dec. 23, 2020 (GLOBE NEWSWIRE) -- At the request of IIROC, Acasti Pharma Inc. (“Acasti or the “Company”)...
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
WEST CHESTER, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing...
Franklin Woods Center Among the First Long-Term Care Facilities in Maryland to Vaccinate Residents and Healthcare Workers
KENNETT SQUARE, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Franklin Woods Center, a Genesis HealthCare- (NYSE:GEN) (Genesis or the Company)...
Galapagos’ CEO makes donation of €10 million in the form of personal shares to African Parks
Mechelen, Belgium; 23 December 2020, 18.00 CET – Galapagos NV (Euronext & NASDAQ: GLPG) today announces that Onno van de...
LifeLabs Confirms that all Members of Santa’s Workshop Have Tested Negative for COVID-19
Santa and team have been cleared for international travel ahead of Christmas LifeLabs Confirms that all Members of Santa’s Workshop...
Elmcroft by Eclipse Senior Living Begins Vaccinating Residents and Associates
Raymond Gano, a resident at Eclipse Senior Living's Elmcroft of Martinsburg community, receives his vaccination. Raymond Gano, a resident at...
Allogene Therapeutics Receives IND Clearance from the U.S. Food and Drug Administration for ALLO-715 in Combination with Nirogacestat in Relapsed/Refractory Multiple Myeloma
Combination Represents One of Allogene’s Three Strategies to Target BCMA for Multiple MyelomaPhase 1 Clinical Trial Expected to Begin in...
UPDATE – GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering
Will Trade on the Nasdaq Global Market Under Ticker “GBS”NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (the...